P. Neven

585 total citations
38 papers, 491 citations indexed

About

P. Neven is a scholar working on Immunology, Oncology and Genetics. According to data from OpenAlex, P. Neven has authored 38 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 9 papers in Oncology and 9 papers in Genetics. Recurrent topics in P. Neven's work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (7 papers), Estrogen and related hormone effects (7 papers) and Curcumin's Biomedical Applications (6 papers). P. Neven is often cited by papers focused on Neutrophil, Myeloperoxidase and Oxidative Mechanisms (7 papers), Estrogen and related hormone effects (7 papers) and Curcumin's Biomedical Applications (6 papers). P. Neven collaborates with scholars based in Belgium, United States and Germany. P. Neven's co-authors include Thierry Franck, J. Delarge, G. Deby‐Dupont, Didier Serteyn, Bernard Pirotte, Ange Mouithys‐Mickalad, Luc Delattre, Gabriel Llabrès, Géraldine Piel and Xavier de Leval and has published in prestigious journals such as Cancer Research, Free Radical Biology and Medicine and Annals of Oncology.

In The Last Decade

P. Neven

36 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Neven Belgium 12 114 72 69 68 67 38 491
Annalisa Cossu Italy 16 243 2.1× 41 0.6× 45 0.7× 75 1.1× 49 0.7× 22 785
Guru R. Valicherla India 19 220 1.9× 33 0.5× 55 0.8× 50 0.7× 112 1.7× 32 662
Chunjing Yang China 17 341 3.0× 55 0.8× 47 0.7× 28 0.4× 25 0.4× 44 775
Santwana Padhi India 10 305 2.7× 21 0.3× 45 0.7× 53 0.8× 131 2.0× 15 843
Takashi Horikawa Japan 19 206 1.8× 147 2.0× 46 0.7× 47 0.7× 185 2.8× 51 850
Zainy M. Banjar Saudi Arabia 17 176 1.5× 29 0.4× 80 1.2× 69 1.0× 60 0.9× 32 759
Anooshirvan Shayeganpour Canada 14 244 2.1× 77 1.1× 119 1.7× 32 0.5× 76 1.1× 20 822
Afrah F. Alkhuriji Saudi Arabia 14 139 1.2× 140 1.9× 33 0.5× 48 0.7× 4 0.1× 51 618
Boxin Zhao China 13 263 2.3× 49 0.7× 57 0.8× 26 0.4× 43 0.6× 24 620

Countries citing papers authored by P. Neven

Since Specialization
Citations

This map shows the geographic impact of P. Neven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Neven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Neven more than expected).

Fields of papers citing papers by P. Neven

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Neven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Neven. The network helps show where P. Neven may publish in the future.

Co-authorship network of co-authors of P. Neven

This figure shows the co-authorship network connecting the top 25 collaborators of P. Neven. A scholar is included among the top collaborators of P. Neven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Neven. P. Neven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rompuy, Anne‐Sophie Van, Toon Van Gorp, Isabelle Vanden Bempt, et al.. (2020). Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-D. Gynecologic Oncology. 157(1). 245–251. 30 indexed citations
2.
Vos, Hanne, Ayse Bassez, Junbin Qian, et al.. (2019). Immune cell dynamics induced by a single dose of pembrolizumab as revealed by single-cell RNA profiling. Annals of Oncology. 30. iii45–iii45. 1 indexed citations
3.
Franck, Thierry, Karim Zouaoui Boudjeltia, Paul G. Furtmüller, et al.. (2018). The soluble curcumin derivative NDS27 inhibits superoxide anion production by neutrophils and acts as substrate and reversible inhibitor of myeloperoxidase. Chemico-Biological Interactions. 297. 34–43. 11 indexed citations
4.
5.
Sonnenblick, Amir, Roberto Salgado, Gert Van den Eynden, et al.. (2015). Constitutively activated STAT3 is predictive for trastuzumab resistance in primary HER2 positive breast cancer. Annals of Oncology. 26. iii15–iii15. 1 indexed citations
6.
Sandersen, Charlotte, et al.. (2015). Effect of inhaled hydrosoluble curcumin on inflammatory markers in broncho-alveolar lavage fluid of horses with LPS-induced lung neutrophilia. Multidisciplinary Respiratory Medicine. 10(1). 16–16. 11 indexed citations
7.
8.
Franck, Thierry, et al.. (2013). Curcumin and resveratrol act by different ways on NADPH oxidase activity and reactive oxygen species produced by equine neutrophils. Chemico-Biological Interactions. 206(2). 186–193. 49 indexed citations
9.
Franck, Thierry, et al.. (2013). Intra- and extracellular antioxidant capacities of the new water-soluble form of curcumin (NDS27) on stimulated neutrophils and HL-60 cells. Chemico-Biological Interactions. 201(1-3). 49–57. 29 indexed citations
10.
Brouckaert, Olivier, Ben Van Calster, Robert Paridaens, et al.. (2012). Abstract P6-07-19: Prognostic relevance of PR and detection mode in Luminal Her-2 negative breast cancer. Cancer Research. 72(24_Supplement). P6–7. 1 indexed citations
11.
Coolen, A C C, Karin Leunen, Johan Menten, W. Van Steenbergen, & P. Neven. (2012). False-negative tests in breast cancer management.. PubMed. 69(7). 324–9. 3 indexed citations
12.
Lamoral‐Theys, Delphine, Laurent Pottier, Frédéric Kerff, et al.. (2010). Simple di- and trivanillates exhibit cytostatic properties toward cancer cells resistant to pro-apoptotic stimuli. Bioorganic & Medicinal Chemistry. 18(11). 3823–3833. 38 indexed citations
13.
14.
Franck, Thierry, Stéphan Kohnen, Sigrid Grulke, et al.. (2008). Inhibitory effect of curcuminoids and tetrahydrocurcuminoids on equine activated neutrophils and myeloperoxidase activity. Physiological Research. 57(4). 577–587. 38 indexed citations
15.
Leval, Xavier de, J. Delarge, P. Neven, et al.. (2001). Evaluation of classical NSAIDs and COX-2 selective inhibitors on purified ovine enzymes and human whole blood. Prostaglandins Leukotrienes and Essential Fatty Acids. 64(4-5). 211–216. 23 indexed citations
16.
Dogné, Jean‐Michel, Stéphanie Rolin, Xavier de Leval, et al.. (2001). Pharmacology of the Thromboxane Receptor Antagonist and Thromboxane Synthase Inhibitor BM‐531. Cardiovascular Drug Reviews. 19(2). 87–96. 26 indexed citations
17.
Pirotte, Bernard, et al.. (1997). The chemistry of 3-phthalimidomethyl-4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxides and their use in the synthesis of potential cholecystokinin/gastrin receptor ligands. Open Repository and Bibliography (University of Liège).
18.
Piel, Géraldine, Bernard Pirotte, P. Neven, et al.. (1997). Study of the Influence of Both Cyclodextrins and L-Lysine on the Aqueous Solubility of Nimesulide; Isolation and Characterization of Nimesulide–L-Lysine–Cyclodextrin Complexes. Journal of Pharmaceutical Sciences. 86(4). 475–480. 81 indexed citations
19.
Tullio, Pascal De, Bernard Pirotte, P. Neven, et al.. (1997). Synthesis and Biological Evaluation of New 3-Aralkylamino-2-aryl-2H-1,2,4-pyridothiadiazine 1,1-dioxides as Potential CCK-Receptor Ligands. Journal of Pharmacy and Pharmacology. 49(5). 463–471. 3 indexed citations
20.
Lieberman, Brian A., E M Belsey, Catherine Wright, et al.. (1978). MENSTRUAL PATTERNS AFTER LAPAROSCOPIC STERILIZATION USING A SPRING‐LOADED CLIP. BJOG An International Journal of Obstetrics & Gynaecology. 85(5). 376–380. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Annalisa Cossu Breakdown of academic impact, for papers by Guru R. Valicherla Breakdown of academic impact, for papers by Chunjing Yang Breakdown of academic impact, for papers by Santwana Padhi Breakdown of academic impact, for papers by Takashi Horikawa Breakdown of academic impact, for papers by Zainy M. Banjar Breakdown of academic impact, for papers by Anooshirvan Shayeganpour Breakdown of academic impact, for papers by Afrah F. Alkhuriji Breakdown of academic impact, for papers by Boxin Zhao
Rankless by CCL
2026